SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-006417
Filing Date
2018-05-09
Accepted
2018-05-09 17:13:01
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q Q1 2018 cpix-20180331.htm   iXBRL 10-Q 776465
2 EXHIBIT 31.1 Q1 2018 q12018-exhibit311.htm EX-31.1 15431
3 EXHIBIT 31.2 Q1 2018 q12018-exhibit312.htm EX-31.2 18025
4 EXHIBIT 32.1 Q1 2018 q12018-exhibit321.htm EX-32.1 11342
  Complete submission text file 0001628280-18-006417.txt   3008872

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20180331.xsd EX-101.SCH 20136
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20180331_cal.xml EX-101.CAL 51880
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20180331_def.xml EX-101.DEF 67960
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20180331_lab.xml EX-101.LAB 256067
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20180331_pre.xml EX-101.PRE 156231
10 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20180331_htm.xml XML 428710
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 18819413
SIC: 2834 Pharmaceutical Preparations